© 1994 Oxford University Press
OTHER |
Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the
1 subunit of the inhibitory glycine receptor
1Departments of Psychological Medicine, University of Wales College of Medicine Health Park, Cardiff CF4, 4XN, UK 2Medical Genetics, University of Wales College of Medicine Health Park, Cardiff CF4 4XN, UK
Received August 1, 1994; Accepted September 16, 1994
Startle disease, or hyperekplexia, is characterized by an exaggerated startle reflex and neonatal hypertonla. An autosomal dominant form of the disorder Is associated with mutations In the same codon of the
1 subunit of the inhibitory glycine receptor (GLRA 1) resulting in the substitution of an uncharged amlno acid for Arg271 in the mature protein. However, recessive transmission Is seen in the mouse mutant spasmodic which resembles startle disease phenotypcially and is also associated with mutations In Glra 1. We have confirmed the finding of Arg271 mutations In individuals with startle disease in a UK family showing autosomal dominant transmission. In addition we describe an apparently sporadic case, the offspring of a consanguineous mating, who Is homozygous for a novel mutation (T1112A) in GLRA 1, which results In the substitution of asparagine for isoleucine at position 244 of the mature protein. This suggests that human startle disease can display recessive as well as dominant inheritance resulting from different mutations in GLRA 1.
*To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Villmann, J. Oertel, Z.-L. Ma-Hogemeier, M. Hollmann, R. Sprengel, K. Becker, H.-G. Breitinger, and C.-M. Becker Functional Complementation of Glra1spd-ot, a Glycine Receptor Subunit Mutant, by Independently Expressed C-Terminal Domains J. Neurosci., February 25, 2009; 29(8): 2440 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Masri and H. A. Hamamy Clinical and Inheritance Profiles of Hyperekplexia in Jordan J Child Neurol, July 1, 2007; 22(7): 895 - 900. [Abstract] [PDF] |
||||
![]() |
L. Doria Lamba, G. Giribaldi, E. De Negri, R. Follo, E. De Grandis, M. Pintaudi, and E. Veneselli A Case of Major Form Familial Hyperekplexia: Prenatal Diagnosis and Effective Treatment With Clonazepam J Child Neurol, June 1, 2007; 22(6): 769 - 772. [Abstract] [PDF] |
||||
![]() |
J. W. Lynch Molecular Structure and Function of the Glycine Receptor Chloride Channel Physiol Rev, October 1, 2004; 84(4): 1051 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Rees, K. Harvey, H. Ward, J. H. White, L. Evans, I. C. Duguid, C. C.-H. Hsu, S. L. Coleman, J. Miller, K. Baer, et al. Isoform Heterogeneity of the Human Gephyrin Gene (GPHN), Binding Domains to the Glycine Receptor, and Mutation Analysis in Hyperekplexia J. Biol. Chem., June 27, 2003; 278(27): 24688 - 24696. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Miraglia Del Giudice, G Coppola, G Bellini, P Ledaal, J M Hertz, and A Pascotto A novel mutation (R218Q) at the boundary between the N-terminal and the first transmembrane domain of the glycine receptor in a case of sporadic hyperekplexia J. Med. Genet., May 1, 2003; 40(5): e71 - 71. [Full Text] [PDF] |
||||
![]() |
D. M. Kullmann The neuronal channelopathies Brain, June 1, 2002; 125(6): 1177 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Rees, T. M. Lewis, J. B. J. Kwok, G. R. Mortier, P. Govaert, R. G. Snell, P. R. Schofield, and M. J. Owen Hyperekplexia associated with compound heterozygote mutations in the {beta}-subunit of the human inhibitory glycine receptor (GLRB) Hum. Mol. Genet., April 1, 2002; 11(7): 853 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Stewart, E. P. Wood, K. E. Gordon, and P. R. Camfield Successful Treatment of Severe Infantile Hyperekplexia With Low-Dose Clobazam J Child Neurol, February 1, 2002; 17(2): 154 - 156. [Abstract] [PDF] |
||||
![]() |
V Praveen, S K Patole, and J S Whitehall Hyperekplexia in neonates Postgrad. Med. J., September 1, 2001; 77(911): 570 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B J Kwok, S. Raskin, G. Morgan, S. A. Antoniuk, I. Bruk, and P. R Schofield Mutations in the glycine receptor {alpha}1 subunit (GLRA1) gene in hereditary hyperekplexia pedigrees: evidence for non-penetrance of mutation Y279C J. Med. Genet., June 1, 2001; 38(6): 17e - 17. [Full Text] |
||||
![]() |
J. W. Lynch, N.-L. R. Han, J. Haddrill, K. D. Pierce, and P. R. Schofield The Surface Accessibility of the Glycine Receptor M2-M3 Loop Is Increased in the Channel Open State J. Neurosci., April 15, 2001; 21(8): 2589 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Saul, T. Kuner, D. Sobetzko, W. Brune, F. Hanefeld, H.-M. Meinck, and C.-M. Becker Novel GLRA1 Missense Mutation (P250T) in Dominant Hyperekplexia Defines an Intracellular Determinant of Glycine Receptor Channel Gating J. Neurosci., February 1, 1999; 19(3): 869 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Moorhouse, P. Jacques, P. H. Barry, and P. R. Schofield The Startle Disease Mutation Q266H, in the Second Transmembrane Domain of the Human Glycine Receptor, Impairs Channel Gating Mol. Pharmacol., February 1, 1999; 55(2): 386 - 395. [Abstract] [Full Text] |
||||
![]() |
J. H. Singer, E. M. Talley, D. A. Bayliss, and A. J. Berger Development of Glycinergic Synaptic Transmission to Rat Brain Stem Motoneurons J Neurophysiol, November 1, 1998; 80(5): 2608 - 2620. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Nikolic, B. Laube, R. G. Weber, P. Lichter, P. Kioschis, A. Poustka, C. Mulhardt, and C.-M. Becker The Human Glycine Receptor Subunit alpha 3. GLRA3 GENE STRUCTURE, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL CHARACTERIZATION OF ALTERNATIVE TRANSCRIPTS J. Biol. Chem., July 31, 1998; 273(31): 19708 - 19714. [Abstract] [Full Text] [PDF] |
||||
![]() |
T M Lewis, L G Sivilotti, D Colquhoun, R M Gardiner, R Schoepfer, and M Rees Properties of human glycine receptors containing the hyperekplexia mutation {alpha}1(K276E), expressed in Xenopus oocytes J. Physiol., February 15, 1998; 507(1): 25 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ranta, A.-E. Lehesjoki, M. d. F. Bonaldo, J. A. Knowles, A. Hirvasniemi, B. Ross, P. J. de Jong, M. B. Soares, A. de la Chapelle, and T. C. Gilliam High-Resolution Mapping and Transcript Identification at the Progressive Epilepsy with Mental Retardation Locus on Chromosome 8p Genome Res., September 1, 1997; 7(9): 887 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Turecki, F. Grand'Maison, B. Lemieux, and G. Rouleau Hyperekplexia and the {alpha}1 Subunit Glycine Receptor Gene (GLRA1) Arch Neurol, September 1, 1996; 53(9): 836 - 837. [Abstract] [PDF] |
||||
![]() |
P.R. Schofield, J.W. Lynch, S. Rajendra, K.D. Pierce, C.A. Handford, and P.H. Barry Molecular and Genetic Insights into Ligand Binding and Signal Transduction at the Inhibitory Glycine Receptor Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 333 - 342. [Abstract] [PDF] |
||||
![]() |
C.-M. Becker Review : Glycine Receptors: Molecular Heterogeneity and Implications for Disease Neuroscientist, May 1, 1995; 1(3): 130 - 141. [Abstract] [PDF] |
||||














